Skip to main content
Erschienen in: Annals of Nuclear Medicine 6/2010

01.07.2010 | Short Communication

Normoglycemic plasma glucose levels affect F-18 FDG uptake in the brain

verfasst von: Jonas Claeys, Koen Mertens, Yves D’Asseler, Ingeborg Goethals

Erschienen in: Annals of Nuclear Medicine | Ausgabe 6/2010

Einloggen, um Zugang zu erhalten

Abstract

Objective

The aim of this study was to investigate whether normoglycemic glucose concentrations interfere with cerebral F-18 FDG uptake.

Methods

The analysis was based on 2 sets of paired PET scans in 94 patients who were in complete metabolic remission after the successful completion of treatment for lymphoma. For these 188 PET scans, 2 subgroups were defined according to the plasma glucose level at the time of scanning. Group 1 contained the PET images that were associated with the lower of both normoglycemic plasma glucose levels, whereas group 2 contained the PET images that were associated with the higher of both plasma glucose levels. SUVs (standard uptake values) in the cerebellum between both groups were compared using paired sample T test. Subsequently, SUVs were normalized to a standard glucose concentration and normalized SUVs were again compared. Further, we calculated the coefficient of variation of SUVs in group 1 and 2 both before and after the normalization step.

Results

Mean plasma glucose level was 86 mg/dL (SD of 9 mg/dL) in group 1 and 97 mg/dL (SD of 10 mg/dL) in group 2. Mean SUV was 3.8 (SD of 1.1) for group 1 and 3.5 (SD of 1.1) for group 2. Mean SUV in group 1 was slightly but statistically significantly higher than the mean SUV in group 2 (p < 0.01). Mean normalized SUV was 3.6 (SD of 1.1) in group 1 and 3.7 (SD of 1.3) in group 2. A paired comparison between normalized SUVs in both groups indicated that there was no statistically significant difference (p < 0.31). The coefficient of variation for the SUVs in group 1 and 2 before normalization was 29 and 30%, respectively. The coefficient of variation for the normalized SUVs in group 1 and 2 was 30 and 34%, respectively.

Conclusions

Our results indicated that plasma glucose levels that are within the normoglycemic range have a small but systematic effect on F-18 FDG uptake in the brain (following an inverse relationship). Normalizing plasma glucose levels to a standard glucose concentration successfully reduced the intra-subject variability of SUV measures. Inter-subject variability, however, remained high suggesting that other factors have an influence as well.
Literatur
1.
Zurück zum Zitat Reivich M, Kuhl D, Wolf A, Greenberg J, Phelps M, Ido T, et al. The [18F] fluorodeoxyglucose method for the measurement of local cerebral glucose utilization in man. Circ Res. 1979;44:127–37.PubMed Reivich M, Kuhl D, Wolf A, Greenberg J, Phelps M, Ido T, et al. The [18F] fluorodeoxyglucose method for the measurement of local cerebral glucose utilization in man. Circ Res. 1979;44:127–37.PubMed
2.
Zurück zum Zitat Phelps ME, Huang SC, Hoffman EJ, Selin C, Sokoloff L, Kuhl DE. Tomographic measurement of local cerebral glucose metabolic rate in humans with (F-18) 2-fluoro-2-deoxy-d-glucose: validation of method. Ann Neurol. 1979;6:371–88.CrossRefPubMed Phelps ME, Huang SC, Hoffman EJ, Selin C, Sokoloff L, Kuhl DE. Tomographic measurement of local cerebral glucose metabolic rate in humans with (F-18) 2-fluoro-2-deoxy-d-glucose: validation of method. Ann Neurol. 1979;6:371–88.CrossRefPubMed
3.
Zurück zum Zitat Thie JA, Smith GT, Hubner KF. 2-deoxy-2-[F-18]fluoro-d-glucose-positron emission tomography sensitivity to serum glucose: a survey and diagnostic applications. Mol Imaging Biol. 2005;7:361–8.CrossRefPubMed Thie JA, Smith GT, Hubner KF. 2-deoxy-2-[F-18]fluoro-d-glucose-positron emission tomography sensitivity to serum glucose: a survey and diagnostic applications. Mol Imaging Biol. 2005;7:361–8.CrossRefPubMed
4.
Zurück zum Zitat Dunn JT, Anthony K, Amiel SA, Marsden PK. Correction for the effect of rising plasma glucose levels on quantification of MR(glc) with FDG-PET. J Cereb Blood Flow Metab. 2009;29:1059–67.CrossRefPubMed Dunn JT, Anthony K, Amiel SA, Marsden PK. Correction for the effect of rising plasma glucose levels on quantification of MR(glc) with FDG-PET. J Cereb Blood Flow Metab. 2009;29:1059–67.CrossRefPubMed
5.
Zurück zum Zitat Ishizu K, Sadato N, Yonekura Y, Nishizawa S, Magata Y, Tamaki N, et al. Enhanced detection of brain tumors by [18F] fluorodeoxyglucose PET with glucose loading. J Comput Assist Tomogr. 1994;18:12–5.CrossRefPubMed Ishizu K, Sadato N, Yonekura Y, Nishizawa S, Magata Y, Tamaki N, et al. Enhanced detection of brain tumors by [18F] fluorodeoxyglucose PET with glucose loading. J Comput Assist Tomogr. 1994;18:12–5.CrossRefPubMed
6.
Zurück zum Zitat Ishizu K, Nishizawa S, Yonekura Y, Sadato N, Magata Y, Tamaki N, et al. Effects of hyperglycemia on FDG uptake in human brain and glioma. J Nucl Med. 1994;35:1104–9.PubMed Ishizu K, Nishizawa S, Yonekura Y, Sadato N, Magata Y, Tamaki N, et al. Effects of hyperglycemia on FDG uptake in human brain and glioma. J Nucl Med. 1994;35:1104–9.PubMed
7.
Zurück zum Zitat Buchert R, Santer R, Brenner W, Apostolova I, Mester J, Clausen M, et al. Computer simulations suggest that acute correction of hyperglycaemia with an insulin bolus protocol might be useful in brain FDG PET. Nuklearmedizin. 2009;48:44–54.PubMed Buchert R, Santer R, Brenner W, Apostolova I, Mester J, Clausen M, et al. Computer simulations suggest that acute correction of hyperglycaemia with an insulin bolus protocol might be useful in brain FDG PET. Nuklearmedizin. 2009;48:44–54.PubMed
8.
Zurück zum Zitat Kawasaki K, Ishii K, Saito Y, Oda K, Kimura Y, Ishiwata K. Influence of mild hyperglycemia on cerebral FDG distribution patterns calculated by statistical parametric mapping. Ann Nucl Med. 2008;22:191–200.CrossRefPubMed Kawasaki K, Ishii K, Saito Y, Oda K, Kimura Y, Ishiwata K. Influence of mild hyperglycemia on cerebral FDG distribution patterns calculated by statistical parametric mapping. Ann Nucl Med. 2008;22:191–200.CrossRefPubMed
9.
Zurück zum Zitat Boellaard R, O’Doherty MJ, Weber WA, Mottaghy FM, Lonsdale MN, Stroobants SG, et al. FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0. Eur J Nucl Med Mol Imaging. 2010;37(1):181–200. Boellaard R, O’Doherty MJ, Weber WA, Mottaghy FM, Lonsdale MN, Stroobants SG, et al. FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0. Eur J Nucl Med Mol Imaging. 2010;37(1):181–200.
10.
Zurück zum Zitat Tsuchida T, Sadato N, Nishizawa S, Yonekura Y, Itoh H. Effect of postprandial hyperglycaemia in non-invasive measurement of cerebral metabolic rate of glucose in non-diabetic subjects. Eur J Nucl Med Mol Imaging. 2002;29:248–50.CrossRefPubMed Tsuchida T, Sadato N, Nishizawa S, Yonekura Y, Itoh H. Effect of postprandial hyperglycaemia in non-invasive measurement of cerebral metabolic rate of glucose in non-diabetic subjects. Eur J Nucl Med Mol Imaging. 2002;29:248–50.CrossRefPubMed
11.
Zurück zum Zitat Turcotte E, Leblanc M, Carpentier A, Benard F. Optimization of whole-body positron emission tomography imaging by using delayed 2-deoxy-2-[F-18]fluoro-d-glucose injection following I.V. Insulin in diabetic patients. Mol Imaging Biol. 2006;8:348–54.CrossRefPubMed Turcotte E, Leblanc M, Carpentier A, Benard F. Optimization of whole-body positron emission tomography imaging by using delayed 2-deoxy-2-[F-18]fluoro-d-glucose injection following I.V. Insulin in diabetic patients. Mol Imaging Biol. 2006;8:348–54.CrossRefPubMed
12.
Zurück zum Zitat Seo YS, Chung TW, Kim IY, Bom HS, Min JJ. Enhanced detectability of recurrent brain tumor using glucose-loading F-18 FDG PET. Clin Nucl Med. 2008;33:32–3.CrossRefPubMed Seo YS, Chung TW, Kim IY, Bom HS, Min JJ. Enhanced detectability of recurrent brain tumor using glucose-loading F-18 FDG PET. Clin Nucl Med. 2008;33:32–3.CrossRefPubMed
13.
Zurück zum Zitat Farid K, Sibon I, Fernandez P, Guyot M, Jeandot R, Allard M. Delayed acquisition and hyperglycemia improve brain metastasis detection on F-18 FDG PET. Clin Nucl Med. 2009;34:533–4.CrossRefPubMed Farid K, Sibon I, Fernandez P, Guyot M, Jeandot R, Allard M. Delayed acquisition and hyperglycemia improve brain metastasis detection on F-18 FDG PET. Clin Nucl Med. 2009;34:533–4.CrossRefPubMed
14.
Zurück zum Zitat Duara R, Gross-Glenn K, Barker WW, Chang JY, Apicella A, Loewenstein D, et al. Behavioral activation and the variability of cerebral glucose metabolic measurements. J Cereb Blood Flow Metab. 1987;7:266–71.PubMed Duara R, Gross-Glenn K, Barker WW, Chang JY, Apicella A, Loewenstein D, et al. Behavioral activation and the variability of cerebral glucose metabolic measurements. J Cereb Blood Flow Metab. 1987;7:266–71.PubMed
15.
Zurück zum Zitat Giordani B, Boivin MJ, Berent S, Betley AT, Koeppe RA, Rothley JM, et al. Anxiety and cerebral cortical metabolism in normal persons. Psychiatry Res. 1990;35:49–60.CrossRefPubMed Giordani B, Boivin MJ, Berent S, Betley AT, Koeppe RA, Rothley JM, et al. Anxiety and cerebral cortical metabolism in normal persons. Psychiatry Res. 1990;35:49–60.CrossRefPubMed
16.
Zurück zum Zitat Franck G, Salmon E, Poirrier R, Sadzot B, Franco G. Study of regional cerebral glucose metabolism, in man, while awake or asleep, by positron emission tomography. Rev Electroencephalogr Neurophysiol Clin. 1987;17:71–7.CrossRefPubMed Franck G, Salmon E, Poirrier R, Sadzot B, Franco G. Study of regional cerebral glucose metabolism, in man, while awake or asleep, by positron emission tomography. Rev Electroencephalogr Neurophysiol Clin. 1987;17:71–7.CrossRefPubMed
17.
Zurück zum Zitat Reivich M, Gur R, Alavi A. Positron emission tomographic studies of sensory stimuli, cognitive processes and anxiety. Hum Neurobiol. 1983;2:25–33.PubMed Reivich M, Gur R, Alavi A. Positron emission tomographic studies of sensory stimuli, cognitive processes and anxiety. Hum Neurobiol. 1983;2:25–33.PubMed
18.
Zurück zum Zitat Gur RC, Gur RE, Resnick SM, Skolnick BE, Alavi A, Reivich M. The effect of anxiety on cortical cerebral blood flow and metabolism. J Cereb Blood Flow Metab. 1987;7:173–7.PubMed Gur RC, Gur RE, Resnick SM, Skolnick BE, Alavi A, Reivich M. The effect of anxiety on cortical cerebral blood flow and metabolism. J Cereb Blood Flow Metab. 1987;7:173–7.PubMed
19.
Zurück zum Zitat Warach S, Gur RC, Gur RE, Skolnick BE, Obrist WD, Reivich M. Decreases in frontal and parietal lobe regional cerebral blood flow related to habituation. J Cereb Blood Flow Metab. 1992;12:546–53.PubMed Warach S, Gur RC, Gur RE, Skolnick BE, Obrist WD, Reivich M. Decreases in frontal and parietal lobe regional cerebral blood flow related to habituation. J Cereb Blood Flow Metab. 1992;12:546–53.PubMed
20.
Zurück zum Zitat Hustinx R, Smith RJ, Benard F, Bhatnagar A, Alavi A. Can the standardized uptake value characterize primary brain tumors on FDG-PET? Eur J Nucl Med. 1999;26:1501–9.CrossRefPubMed Hustinx R, Smith RJ, Benard F, Bhatnagar A, Alavi A. Can the standardized uptake value characterize primary brain tumors on FDG-PET? Eur J Nucl Med. 1999;26:1501–9.CrossRefPubMed
21.
Zurück zum Zitat Paquet N, Albert A, Foidart J, Hustinx R. Within-patient variability of (18)F-FDG: standardized uptake values in normal tissues. J Nucl Med. 2004;45:784–8.PubMed Paquet N, Albert A, Foidart J, Hustinx R. Within-patient variability of (18)F-FDG: standardized uptake values in normal tissues. J Nucl Med. 2004;45:784–8.PubMed
22.
Zurück zum Zitat Wang GJ, Volkow ND, Wolf AP, Brodie JD, Hitzemann RJ. Intersubject variability of brain glucose metabolic measurements in young normal males. J Nucl Med. 1994;35:1457–66.PubMed Wang GJ, Volkow ND, Wolf AP, Brodie JD, Hitzemann RJ. Intersubject variability of brain glucose metabolic measurements in young normal males. J Nucl Med. 1994;35:1457–66.PubMed
23.
Zurück zum Zitat Westerterp M, Pruim J, Oyen W, Hoekstra O, Paans A, Visser E, et al. Quantification of FDG PET studies using standardised uptake values in multi-centre trials: effects of image reconstruction, resolution and ROI definition parameters. Eur J Nucl Med Mol Imaging. 2007;34:392–404.CrossRefPubMed Westerterp M, Pruim J, Oyen W, Hoekstra O, Paans A, Visser E, et al. Quantification of FDG PET studies using standardised uptake values in multi-centre trials: effects of image reconstruction, resolution and ROI definition parameters. Eur J Nucl Med Mol Imaging. 2007;34:392–404.CrossRefPubMed
24.
Zurück zum Zitat Boellaard R. Standards for PET image acquisition and quantitative data analysis. J Nucl Med. 2009;50(Suppl 1):11S–20S.CrossRefPubMed Boellaard R. Standards for PET image acquisition and quantitative data analysis. J Nucl Med. 2009;50(Suppl 1):11S–20S.CrossRefPubMed
Metadaten
Titel
Normoglycemic plasma glucose levels affect F-18 FDG uptake in the brain
verfasst von
Jonas Claeys
Koen Mertens
Yves D’Asseler
Ingeborg Goethals
Publikationsdatum
01.07.2010
Verlag
Springer Japan
Erschienen in
Annals of Nuclear Medicine / Ausgabe 6/2010
Print ISSN: 0914-7187
Elektronische ISSN: 1864-6433
DOI
https://doi.org/10.1007/s12149-010-0359-9

Weitere Artikel der Ausgabe 6/2010

Annals of Nuclear Medicine 6/2010 Zur Ausgabe